RVC Biofund’s portfolio company – Semiotic – entered into a contract with the India’s Yashraj Biotechnology Ltd. (top-20 company on the Indian pharmaceutical market) to supply its researched carbohydrate (glycochip) for qualitative determination of glycan-connecting proteins.
Moscow Seed Fund jointly with RVC Biofund invested RUB 12,000,000 into "Central Factory of Prepared Media» Project.
Portfolio companies of PrimeBioMed RVC Biofund has certified the quality management system in compliance with international standard ISO 13485.
Opening of the first Russian laboratory for the production of antibodies for the diagnosis of cancer and the development of diagnostic systems based on them - PraymBioMed, - took place on December 4 in the "Slava" tech park.